Outcomes from the ClotTriever Outcomes Registry show symptom duration may underestimate deep vein thrombus chronicity
- 14 June 2022
- journal article
- conference paper
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 10 (6) , 1251-1259
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized TrialJournal of Vascular and Interventional Radiology, 2020
- Association of Successful Ultrasound-Accelerated Catheter-Directed Thrombolysis with Postthrombotic Syndrome: A Post Hoc Analysis of the CAVA TrialThrombosis and Haemostasis, 2020
- The distinctive structure and composition of arterial and venous thrombi and pulmonary emboliScientific Reports, 2020
- Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trialThe Lancet Haematology, 2020
- Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein ThrombosisNew England Journal of Medicine, 2017
- Can thrombus age guide thrombolytic therapy?Cardiovascular Diagnosis and Therapy, 2017
- A histological and functional description of the tissue causing chronic postthrombotic venous obstructionThrombosis Research, 2015
- Duplex Ultrasound in the Diagnosis of Lower-Extremity Deep Venous ThrombosisCirculation, 2014
- Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trialThe Lancet, 2012
- Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patencyJournal of Thrombosis and Haemostasis, 2009